Shaari Ariana L, Kumar Keshav, Saad Anthony M, Patel Aman M, Cowan Paul, Filimonov Andrey, Mir Ghayoour S
Department of Otolaryngology Rutgers New Jersey Medical School Newark New Jersey USA.
Laryngoscope Investig Otolaryngol. 2025 Sep 13;10(5):e70220. doi: 10.1002/lio2.70220. eCollection 2025 Oct.
Frailty is a predictor of poor outcomes following surgery for malignancy. Our study investigates the association between the modified 5-item frailty index (mFI-5) and postoperative outcomes following parotidectomy for malignancy.
Cross-sectional database study.
National Surgical Quality Improvement Program (NSQIP).
The 2005-2018 NSQIP was retrospectively queried for patients undergoing parotidectomy for malignancy. Cases were stratified by the modified 5-item frailty index (mFI-5), which was calculated by the presence of 5 comorbidities: hypertension requiring medication, diabetes mellitus, congestive heart failure in the last 30 days, lung pathology, and functional health status. Univariate and multivariate analyses were performed to identify associations between mFI-5 and demographic, comorbid, and complication variables.
A total of 14,567 patients were identified and stratified by the mFI-5. Univariate analysis showed an increasing incidence of American Society of Anesthesiologists (ASA) class, all comorbidities, and all complications with increasing mFI-5 score ( < 0.001). Multivariable regressions showed increased odds of any surgical complication in patients with mFI-5 ≥ 2 compared with mFI-5 = 0 (aOR 2.56; 95% CI: 1.37-4.76, = 0.011), as well as increased odds of unplanned readmission (aOR 4.02; 95% CI: 1.16-13.97, = 0.032) and reoperation (aOR 6.61; 95% CI: 1.07-40.68, = 0.042).
The mFI-5 is associated with increased incidence of comorbidities and complications, as well as increased odds of surgical complications, unplanned readmission, and reoperation in patients undergoing parotidectomy for malignancy, independent of age and ASA class. The mFI-5 can be utilized in the risk stratification of these patients.
衰弱是恶性肿瘤手术后预后不良的一个预测因素。我们的研究调查了改良的5项衰弱指数(mFI-5)与恶性肿瘤腮腺切除术后的术后结局之间的关联。
横断面数据库研究。
国家外科质量改进计划(NSQIP)。
对2005 - 2018年NSQIP中接受恶性肿瘤腮腺切除术的患者进行回顾性查询。病例根据改良的5项衰弱指数(mFI-5)进行分层,该指数通过存在5种合并症来计算:需要药物治疗的高血压、糖尿病、过去30天内的充血性心力衰竭、肺部病变以及功能健康状况。进行单因素和多因素分析以确定mFI-5与人口统计学、合并症和并发症变量之间的关联。
共识别出14567例患者,并根据mFI-5进行分层。单因素分析显示,随着mFI-5评分增加,美国麻醉医师协会(ASA)分级、所有合并症以及所有并发症的发生率均升高(P < 0.001)。多变量回归显示,与mFI-5 = 0相比,mFI-5≥2的患者发生任何手术并发症的几率增加(调整后比值比[aOR] 2.56;95%置信区间[CI]:1.37 - 4.76,P = 0.011),以及计划外再入院几率增加(aOR 4.02;95% CI:1.16 - 13.97,P = 0.032)和再次手术几率增加(aOR 6.61;95% CI:1.07 - 40.68,P = 0.042)。
mFI-5与合并症和并发症的发生率增加相关,并且在接受恶性肿瘤腮腺切除术的患者中,手术并发症、计划外再入院和再次手术的几率增加,独立于年龄和ASA分级。mFI-5可用于这些患者的风险分层。